Reyataz, Lunesta win MM&M Gold Awards

Share this article:

The marketers behind Reyataz and Lunesta took top honors at last night's 2005 MM&M Awards.

Sepracor, together with partners Zeno Group, McCann Humancare and Echo Torre Lazur, won the MM&M Gold Award for Best Total Integration Program in a company under $5 billion in sales, based on the launch of Lunesta, with an honorable mention going to molecular testing systems firm Cepheid and agency ODA for their work on the Cepheid brand campaign.

Bristol-Myers Squibb, along with Euro RSCG Life Adrenaline, won the MM&M Gold Award for Best Total Integration Program in a company over $5 billion in sales for the launch of Reyataz. An honorable mention for the category went to Amgen and Abelson-Taylor for their work on the launch of Kepivance. 

The MM&M Awards, presented Wednesday, Nov. 9 at New York City's Tavern on the Green, recognize the year's best work in medical marketing across all disciplines as judged by a panel of the industry's top talents. Emceed by comedian Adam Ferrara, the lavish event was attended by more than 600 leading marketers.

Other awards included:

Best TV Campaign to Roche Diagnostics and BBDO Chicago for Accu-Chek "Twins" and "Yaa" spots, with an honorable mention going to Allergan and Grey Worldwide for Botox Cosmetic "Special Occasions" campaign

Best Overall Campaign in Consumer Press to Allergan and Jeffery Simbrow & Associates for Botox Cosmetic "Me, Myself and I" campaign, with an honorable mention going to GlaxoSmithKline and Grey Worldwide for Imitrex Monster campaign

Best Overall Campaign in Business Press to Pfizer and Euro RSCG Life LM&P for Estring "Below the Belt" campaign, with an honorable mention going to Wyeth and Grey Healthcare Group for ReFacto "Shadow" ad

Best Use of Public Relations to Pfizer and APCO Worldwide for The Pfizer Share Card: Committment to Access, with an honorable mention going to Allergan and Chandler Chicco Agency for Prevage Antioxidant Cream work

Healthcare Consumer Publication of the Year to Southern Progress Corporation's Health Magazine, with an honorable mention to The Association of Women's Health, Obstetric and Neonatal Nurses for Every Woman Magazine

Healthcare Business Publication of the Year to Elsevier/BioLink Communications' Community Oncology, with an honorable mention going to Thomson Professional Postgraduate Services' Lipid Management newsletter

Healthcare Web Site of the Year to the American Academy of Family Physicians for FamilyDoctor.org, with an honorable mention going to the National Diabetes Education Initiative for NDEI.org

Best Media Buying or Planning to Aventis and Starcom USA for Lantus media plan, with an honorable mention to Alcon Labs and Communications Media Inc. for Panatol NCO work

Best Individual Product Advertisement in Consumer Press to AstraZeneca and Quantum for Crestor "Oats, Carrots, Sneakers" ad, with an honorable mention going to Forest Health, Berix Clinics and Unit 7 for America's Leader ad

Best Product Launch Advertisement in Consumer Press to Digene and Gotham, Inc. for The HPV Test "Not a Pap" ad, with an honorable mention to Forest Health, Barix Clinics and Unit 7 for America's Leader ad

Best Individual Product Advertisement in Business Press to Medpointe and Wishbone/ITP for Zomig "Faster Than Fast" ad, with an honorable mention going to Connetics Corp. and Abelson-Taylor for Evoclin journal ad

Best Product Launch Advertisement in Business Press to Connetics Corp. and Abelson-Taylor Inc. for Evoclin journal ad, with an honorable mention to Coria and Balcom Agency for "Salex: Before, After" ad

Best Use of Digital Marketing to Consumers to Serono and Cramer for FertilityLifeLines.com, with an honorable mention to AstraZeneca and SimStar for EverydayKidz.com

Best Use of Digital Marketing to Healthcare Professionals to Takeda Pharmaceuticals and Shaw Science Partners for ScienceofSleep.com, with an honorable mention going to GE Healthcare and Est

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...